Accelerated atherosclerosis, arterial thromboembolism, and preventive strategies in systemic lupus erythematosus

Scandinavian Journal of Rheumatology
C C Mok

Abstract

With improved disease survival, arterial thromboembolism has become an important cause of morbidity in patients with systemic lupus erythematosus (SLE). A number of conventional and non-conventional risk factors are associated with accelerated atherosclerosis. Regular surveillance and control of traditional risk factors is mandatory, and so is the appropriate use of the statins, anti-malarial agents, anti-platelet agents, and anti-coagulation for primary and secondary prevention of arterial thromboembolism in SLE patients. Judicious use of corticosteroids, calcineurin inhibitors, hormonal replacement therapy, and the cyclooxygenase 2 inhibitors is equally important.

References

Feb 1, 1976·The American Journal of Medicine·M B UrowitzM A Ogryzlo
Nov 1, 1992·The American Journal of Medicine·M PetriM C Hochberg
Jan 1, 1992·Annals of the Rheumatic Diseases·J McDonaldD D Gladman
Nov 7, 1996·The New England Journal of Medicine·C A RoldanM H Crawford
May 26, 1999·Annals of the Rheumatic Diseases·I N BruceM B Urowitz
Dec 11, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·L J Pinderski OslundA I Fyfe
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais
Apr 17, 2001·Hypertension·F SelzerS Manzi
Oct 17, 2001·Circulation·E SvenungssonJ Frostegård
Feb 20, 2002·JAMA : the Journal of the American Medical Association·Elizabeth Barrett-ConnorUNKNOWN MORE Investigators (Multiple Outcomes of Raloxifene Evaluation)
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Dec 11, 2002·Best Practice & Research. Clinical Rheumatology·Michelle Petri
Dec 27, 2002·The New England Journal of Medicine·Francis K L ChanJoseph J Y Sung
Mar 18, 2003·Immunobiology·Eiji MatsuuraGraham R V Hughes
May 31, 2003·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mark J Sarnak
Jul 10, 2003·Autoimmunity Reviews·Eiji MatsuuraYehuda Shoenfeld
Aug 19, 2003·Annals of the Rheumatic Diseases·K MangerB Manger

❮ Previous
Next ❯

Citations

Dec 4, 2009·Expert Review of Cardiovascular Therapy·Dolores PuenteRicardo Forastiero
May 3, 2013·Expert Review of Clinical Immunology·Chi Chiu Mok
Feb 13, 2010·Expert Opinion on Emerging Drugs·Chi Chiu Mok
Oct 27, 2006·Expert Opinion on Emerging Drugs·Chi Chiu Mok
Jul 28, 2007·Scandinavian Journal of Rheumatology·K K SallaiP Gergely
Mar 25, 2009·Scandinavian Journal of Rheumatology·S Ekblom-KullbergH Julkunen
Dec 18, 2009·Autoimmunity·Yaniv ShererYehuda Shoenfeld
Jul 14, 2009·Best Practice & Research. Clinical Rheumatology·Jennifer R Elliott, Susan Manzi
Nov 26, 2008·Survey of Ophthalmology·Morgan GauntMichael S Lee
Apr 27, 2007·International Journal of Cardiology·Chi-Hang LeeHuay-Cheem Tan
Nov 7, 2006·International Journal of Cardiology·Chi-Hang Lee, Mark Y Chan
Feb 6, 2010·Scandinavian Journal of Rheumatology·K AlmehedH Forsblad-d'Elia
May 2, 2013·Maturitas·Preeta Kaur Chugh
May 21, 2008·Lupus·M D Lockshin, R H W M Derksen
Dec 28, 2017·Auto- Immunity Highlights·Tohid HassanalilouYaser Khaje Bishak
Jan 20, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Iris Z JaffeMichael E Mendelsohn
May 16, 2007·Current Rheumatology Reports·Jennifer Rae ElliottDaniel Edmundowicz
Aug 1, 2007·Nature Clinical Practice. Rheumatology·Deborah AlpertJane E Salmon
Jan 27, 2010·Clinical Rheumatology·Chi Chiu MokChi Hung To
May 17, 2019·Expert Review of Clinical Immunology·Chi Chiu Mok

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.